First Citizens Bank & Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.8M Buy
31,493
+1,546
+5% +$1.58M 0.56% 27
2026
Q1
$27.5M Buy
29,947
+644
+2% +$653K 0.58% 29
2025
Q4
$31.5M Buy
29,303
+4,669
+19% +$4.46M 0.66% 22
2025
Q3
$18.8M Buy
24,634
+9,121
+59% +$6.79M 0.41% 38
2025
Q2
$12.1M Buy
15,513
+1,782
+13% +$1.38M 0.22% 64
2025
Q1
$11.3M Buy
13,731
+237
+2% +$197K 0.29% 56
2024
Q4
$10.4M Buy
13,494
+337
+3% +$279K 0.19% 58
2024
Q3
$11.7M Buy
13,157
+4,339
+49% +$3.9M 0.26% 60
2024
Q2
$7.98M Sell
8,818
-52
-0.6% -$41.6K 0.15% 78
2024
Q1
$6.9M Buy
8,870
+3,940
+80% +$2.8M 0.13% 88
2023
Q4
$2.87M Buy
4,930
+543
+12% +$317K 0.05% 134
2023
Q3
$2.36M Sell
4,387
-153
-3% -$78.8K 0.05% 141
2023
Q2
$2.13M Buy
4,540
+286
+7% +$120K 0.04% 159
2023
Q1
$1.46M Sell
4,254
-414
-9% -$140K 0.03% 167
2022
Q4
$1.71M Sell
4,668
-965
-17% -$342K 0.05% 146
2022
Q3
$1.82M Sell
5,633
-636
-10% -$202K 0.06% 134
2022
Q2
$2.03M Buy
6,269
+2,304
+58% +$692K 0.07% 120
2022
Q1
$1.14M Buy
3,965
+24
+0.6% +$6.18K 0.04% 164
2021
Q4
$1.09M Buy
3,941
+679
+21% +$172K 0.04% 168
2021
Q3
$754K Sell
3,262
-3,121
-49% -$770K 0.04% 182
2021
Q2
$1.47M Sell
6,383
-456
-7% -$91.6K 0.07% 143
2021
Q1
$1.28M Sell
6,839
-110
-2% -$21.5K 0.06% 173
2020
Q4
$1.17M Sell
6,949
-1,184
-15% -$177K 0.06% 163
2020
Q3
$1.2M Sell
8,133
-1,546
-16% -$239K 0.08% 172
2020
Q2
$1.59M Buy
9,679
+6,198
+178% +$951K 0.13% 144
2020
Q1
$483K Sell
3,481
-54
-2% -$7.42K 0.06% 200
2019
Q4
$464K Buy
3,535
+48
+1% +$5.56K 0.04% 222
2019
Q3
$390K Buy
3,487
+1,079
+45% +$120K 0.05% 240
2019
Q2
$267K Sell
2,408
-10,470
-81% -$1.23M 0.03% 369
2019
Q1
$1.67M Buy
12,878
+2,284
+22% +$278K 0.19% 135
2018
Q4
$1.23M Sell
10,594
-4,448
-30% -$497K 0.15% 154
2018
Q3
$1.61M Buy
15,042
+11,577
+334% +$1.16M 0.18% 151
2018
Q2
$296K Buy
+3,465
New +$285K 0.04% 342
2018
Q1
Sell
-3,468
Closed -$293K 419
2017
Q4
$293K Sell
3,468
-5,497
-61% -$468K 0.04% 308
2017
Q3
$767K Buy
8,965
+5,669
+172% +$465K 0.1% 183
2017
Q2
$272K Sell
3,296
-1,919
-37% -$157K 0.04% 369
2017
Q1
$439K Sell
5,215
-526
-9% -$42.1K 0.05% 262
2016
Q4
$422K Sell
5,741
-179
-3% -$13.3K 0.05% 250
2016
Q3
$476K Buy
5,920
+18
+0.3% +$1.44K 0.04% 261
2016
Q2
$465K Sell
5,902
-172
-3% -$12.9K 0.04% 299
2016
Q1
$438K Sell
6,074
-65,587
-92% -$4.96M 0.04% 296
2015
Q4
$6.04M Sell
71,661
-7,086
-9% -$588K 0.44% 74
2015
Q3
$6.59M Sell
78,747
-30,873
-28% -$2.61M 0.49% 68
2015
Q2
$9.15M Sell
109,620
-111,554
-50% -$8.5M 0.63% 53
2015
Q1
$16.1M Sell
221,174
-51,289
-19% -$3.65M 1.11% 27
2014
Q4
$18.8M Sell
272,463
-4,357
-2% -$294K 1.44% 12
2014
Q3
$18M Buy
276,820
+13,702
+5% +$868K 1.47% 13
2014
Q2
$16.4M Sell
263,118
-13,212
-5% -$788K 1.39% 12
2014
Q1
$16.3M Buy
276,330
+8,447
+3% +$471K 1.47% 9
2013
Q4
$13.7M Sell
267,883
-75,800
-22% -$3.8M 1.24% 22
2013
Q3
$17.3M Buy
343,683
+51,682
+18% +$2.71M 0.66% 24
2013
Q2
$14.3M Buy
+292,001
New +$15.9M 0.59% 31

Other funds holding LLY

First Citizens Bank & Trust's LLY Position: Q2 2026 in Review

First Citizens Bank & Trust increased its Eli Lilly (LLY) stake by 5.2% in Q2 2026, buying an estimated $1.58M and bringing the position to 31,493 shares worth $37.8M. The position accounts for 0.56% of the portfolio, ranked #27.

First Citizens Bank & Trust first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. 881 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • First Citizens Bank & Trust held 31,493 shares of Eli Lilly worth $37.8M as of Q2 2026.
  • First Citizens Bank & Trust bought 1,546 Eli Lilly shares in Q2 2026, an estimated $1.58M.
  • Eli Lilly made up 0.56% of First Citizens Bank & Trust's portfolio in Q2 2026, its #27 holding.
  • First Citizens Bank & Trust first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • 881 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on First Citizens Bank & Trust's 13F filing for Q2 2026, filed 13 Jul 2026.